| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Division of Geographic Medicine, Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland, Ohio 44106
Abstract
Spontaneous diminution of granuloma formation around schistosome eggs in chronic schistosomiasis mansoni has been demonstrated previously. In the present study these findings were confirmed by injecting schistosome eggs into the pulmonary microvasculature and removing the lungs 8 days later from mice infected for 4, 8, 12, 16, and 20 weeks; the mean area of inflammation around the eggs was then measured. At 4 weeks a primary reaction was seen, by 8 weeks a massive secondary reaction occurred, but by 12 weeks the lesion was considerably reduced in size, and at 20 weeks it was smaller than the primary reaction. Concomitant measurements of humoral hemagglutinins to soluble egg antigens (SEA) revealed no detectable antibodies at 4 and 6 weeks, relatively low levels at 8 weeks, and an exponential increase in hemagglutinins at 12 weeks and beyond. Immunodiffusion analysis revealed no precipitins at 8 weeks, 1 major band and 2 minor bands at 12 and 16 weeks, and 2 major bands and 1 minor band at 20 weeks. Spleen cells from 8-week-infected mice showed peak migration inhibitory factor (MIF) output at a concentration of 1 µg/ml of soluble egg antigens and suppression of lymphokine secretion at higher concentrations. At 12 and 16 weeks, exponentially lower antigen concentrations both stimulated and suppressed peak MIF output; at 20 weeks MIF was not detectable after stimulation over a wide range of antigen concentrations. Delayed footpad swelling to SEA reached its peak at 10 weeks and declined thereafter, but the response to PPD in tuberculin-sensitized schistosome infected mice remained constant over the period of time studied.
Footnotes
1 These investigations were supported by Grant AI 08163 from the U. S. Public Health Service and by The Edna McConnell Clark Foundation.
This article has been cited by other articles:
|
|
 |
|
  F. L. Oliveira, P. Frazao, R. Chammas, D. K. Hsu, F. T. Liu, R. Borojevic, C. M. Takiya, and M. C. El-Cheikh Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3 / mice J. Leukoc. Biol., August 1, 2007; 82(2): 300 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Shainheit, R. Saraceno, L. E. Bazzone, L. I. Rutitzky, and M. J. Stadecker Disruption of Interleukin-27 Signaling Results in Impaired Gamma Interferon Production but Does Not Significantly Affect Immunopathology in Murine Schistosome Infection Infect. Immun., June 1, 2007; 75(6): 3169 - 3177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Heninger, L. H. Hogan, J. Karman, S. Macvilay, B. Hill, J. P. Woods, and M. Sandor Characterization of the Histoplasma capsulatum-Induced Granuloma. J. Immunol., September 1, 2006; 177(5): 3303 - 3313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Taylor, M. Mohrs, and E. J. Pearce Regulatory T Cell Responses Develop in Parallel to Th Responses and Control the Magnitude and Phenotype of the Th Effector Populatio J. Immunol., May 15, 2006; 176(10): 5839 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. d. S. Pyrrho, J. A. Ramos, R. M. Neto, C. S. d. Silva, H. L. Lenzi, C. M. Takiya, and C. R. Gattass Dexamethasone, a Drug for Attenuation of Schistosoma mansoni Infection Morbidity Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3490 - 3498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Lundy and D. L. Boros Fas Ligand-Expressing B-1a Lymphocytes Mediate CD4+-T-Cell Apoptosis during Schistosomal Infection: Induction by Interleukin 4 (IL-4) and IL-10 Infect. Immun., February 1, 2002; 70(2): 812 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Lundy, S. P. Lerman, and D. L. Boros Soluble Egg Antigen-Stimulated T Helper Lymphocyte Apoptosis and Evidence for Cell Death Mediated by FasL+ T and B Cells during Murine Schistosoma mansoni Infection Infect. Immun., January 1, 2001; 69(1): 271 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Rumbley, S. A. Zekavat, H. Sugaya, P. J. Perrin, M. A. Ramadan, and S. M. Phillips The Schistosome Granuloma: Characterization of Lymphocyte Migration, Activation, and Cytokine Production J. Immunol., October 15, 1998; 161(8): 4129 - 4137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen and D. L. Boros Identification of the Immunodominant T Cell Epitope of p38, a Major Egg Antigen, and Characterization of the Epitope-Specific Th Responsiveness During Murine Schistosomiasis Mansoni J. Immunol., June 1, 1998; 160(11): 5420 - 5427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jankovic, A. W. Cheever, M. C. Kullberg, T. A. Wynn, G. Yap, P. Caspar, F. A. Lewis, R. Clynes, J. V. Ravetch, and A. Sher CD4+ T Cell-mediated Granulomatous Pathology in Schistosomiasis Is Downregulated by a B Cell-dependent Mechanism Requiring Fc Receptor Signaling J. Exp. Med., February 16, 1998; 187(4): 619 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Montesano, D. G. Colley, M. T. Willard, G. L. Freeman Jr., and W. E. Secor Idiotypes Expressed Early in Experimental Schistosoma mansoni Infections Predict Clinical Outcomes of Chronic Disease J. Exp. Med., May 6, 2002; 195(9): 1223 - 1228. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
